• COVID-19
  • Biosimilars
  • Cataract Therapeutics
  • DME
  • Gene Therapy
  • Workplace
  • Ptosis
  • Optic Relief
  • Imaging
  • Geographic Atrophy
  • AMD
  • Presbyopia
  • Ocular Surface Disease
  • Practice Management
  • Pediatrics
  • Surgery
  • Therapeutics
  • Optometry
  • Retina
  • Cataract
  • Pharmacy
  • IOL
  • Dry Eye
  • Understanding Antibiotic Resistance
  • Refractive
  • Cornea
  • Glaucoma
  • OCT
  • Ocular Allergy
  • Clinical Diagnosis
  • Technology

Refractive Cataract Surgery: Setting expectations for premium cataract outcomes

Article

Part 6 of 6

 

Refractive Cataract Surgery: Setting expectations for premium cataract outcomes

As more people are working and staying active later in life, interest in presbyopia-correcting IOLs among cataract surgery patients seems to be growing. At the same time, not all patients are aware of this option. Sheri Rowen, MD, explains how she educates patients about presbyopia-correcting IOLs and the value of premium cataract surgery. She also describes elements of the preoperative clinical examination that are key for patient selection.

Read the article now

Sponsored by:

 

 

   

Related Videos
© 2024 MJH Life Sciences

All rights reserved.